Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P8PG
|
||||
Former ID |
DNC013123
|
||||
Drug Name |
1-(4-bromophenethyl)-1H-imidazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C11H11BrN2
|
||||
Canonical SMILES |
C1=CC(=CC=C1CCN2C=CN=C2)Br
|
||||
InChI |
1S/C11H11BrN2/c12-11-3-1-10(2-4-11)5-7-14-8-6-13-9-14/h1-4,6,8-9H,5,7H2
|
||||
InChIKey |
PAYXPBIBNFYADE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Superpathway of steroid hormone biosynthesis | ||||
Glucocorticoid biosynthesis | |||||
Androgen biosynthesis | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolic pathways | |||||
Ovarian steroidogenesis | |||||
Prolactin signaling pathway | |||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Steroidogenesis | |||||
Reactome | Androgen biosynthesis | ||||
Glucocorticoid biosynthesis | |||||
Endogenous sterols | |||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compounds | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2006 Sep 15;16(18):4752-6. Epub 2006 Jul 25.Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.